|
Name |
10-Undecynoic acid
|
Molecular Formula | C11H18O2 | |
IUPAC Name* |
undec-10-ynoic acid
|
|
SMILES |
C#CCCCCCCCCC(=O)O
|
|
InChI |
InChI=1S/C11H18O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h1H,3-10H2,(H,12,13)
|
|
InChIKey |
OAOUTNMJEFWJPO-UHFFFAOYSA-N
|
|
Synonyms |
10-Undecynoic acid; Undec-10-ynoic acid; 2777-65-3; Hendecynoic acid; 2F79G7H1WY; Undec-10-ynoicacid; EINECS 220-471-8; BRN 1704918; UNII-2F79G7H1WY; MFCD00014389; Undec-1-yn-11-oic acid; 10-HENDECYNOIC ACID; SCHEMBL40510; 10-Undecynoic acid, 95%; 4-02-00-01738 (Beilstein Handbook Reference); LCZC1163; DTXSID2075219; CHEBI:185054; ZINC2015667; GEO-02443; LMFA01030618; STL554898; AKOS001592014; AT18751; AS-57177; DB-047276; CS-0160163; FT-0607205; U0054; J-802018; W-200273; Q18611669
|
|
CAS | 2777-65-3 | |
PubChem CID | 31039 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 182.26 | ALogp: | 3.3 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.46 |
Caco-2 Permeability: | -4.87 | MDCK Permeability: | 0.00002720 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.172 |
30% Bioavailability (F30%): | 0.919 |
Blood-Brain-Barrier Penetration (BBB): | 0.96 | Plasma Protein Binding (PPB): | 95.46% |
Volume Distribution (VD): | 0.352 | Fu: | 1.81% |
CYP1A2-inhibitor: | 0.09 | CYP1A2-substrate: | 0.411 |
CYP2C19-inhibitor: | 0.042 | CYP2C19-substrate: | 0.4 |
CYP2C9-inhibitor: | 0.143 | CYP2C9-substrate: | 0.966 |
CYP2D6-inhibitor: | 0.025 | CYP2D6-substrate: | 0.132 |
CYP3A4-inhibitor: | 0.023 | CYP3A4-substrate: | 0.034 |
Clearance (CL): | 1.771 | Half-life (T1/2): | 0.808 |
hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.067 |
Drug-inuced Liver Injury (DILI): | 0.039 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 0.164 | Maximum Recommended Daily Dose: | 0.044 |
Skin Sensitization: | 0.686 | Carcinogencity: | 0.552 |
Eye Corrosion: | 0.955 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.761 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000088 | 0.683 | D0Z5BC | 0.636 | ||||
ENC000270 | 0.636 | D0E4WR | 0.543 | ||||
ENC000720 | 0.634 | D0FD0H | 0.463 | ||||
ENC000263 | 0.610 | D0Y8DP | 0.400 | ||||
ENC000102 | 0.596 | D0XN8C | 0.397 | ||||
ENC001228 | 0.596 | D0O1PH | 0.378 | ||||
ENC000647 | 0.568 | D0O1TC | 0.356 | ||||
ENC000075 | 0.543 | D07ILQ | 0.333 | ||||
ENC000030 | 0.537 | D0I4DQ | 0.329 | ||||
ENC000378 | 0.528 | D03ZJE | 0.319 |